pert_iname,cell_iname,norm_cs,bioactivity_class,SMILE
CC-401,MDAMB231,2.33,active,C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5
amsacrine,MDAMB231,2.13,active,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42
aphidicolin,MDAMB231,2.12,active,C[C@]12CC[C@H]([C@@]([C@@H]1CC[C@@H]3[C@@]24CC[C@@]([C@H](C3)C4)(CO)O)(C)CO)O
pelitinib,MDAMB231,2.04,active,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C
SB-239063,MDAMB231,1.91,active,COC1=NC=CC(=N1)C2=C(N=CN2C3CCC(CC3)O)C4=CC=C(C=C4)F
MLN-8054,MDAMB231,1.87,active,C1C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=C(C=CC=C4F)F)NC5=CC=C(C=C5)C(=O)O
selumetinib,MDAMB231,1.85,active,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
PHA-767491,MDAMB231,1.83,active,C1CNC(=O)C2=C1NC(=C2)C3=CC=NC=C3
valrubicin,MDAMB231,1.77,active,CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O
GW-843682X,MDAMB231,1.75,active,COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC
Y-39983,MDAMB231,1.75,active,C[C@H](C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N
PF-477736,MDAMB231,1.72,active,CN1C=C(C=N1)C2=C3C=NNC(=O)C4=C3C(=CC(=C4)NC(=O)[C@@H](C5CCCCC5)N)N2
tozasertib,MDAMB231,1.71,active,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C
alaproclate,MDAMB231,1.64,active,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N
tazarotene,MDAMB231,1.63,active,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C
famotidine,MDAMB231,1.62,active,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N
cisapride,MDAMB231,1.62,active,CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F
bosutinib,MDAMB231,1.62,active,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC
idebenone,MDAMB231,1.6,active,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO
trifluridine,MDAMB231,1.6,active,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O
brivudine,MDAMB231,1.58,active,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)CO)O
terbinafine,MDAMB231,1.57,active,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21
palovarotene,MDAMB231,1.57,active,CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
enzastaurin,MDAMB231,1.56,active,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7
fusidic-acid,MDAMB231,1.55,active,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C
mericitabine,MDAMB231,1.55,active,CC(C)C(=O)OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C
motesanib,MDAMB231,1.55,active,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C
zonisamide,MDAMB231,1.55,active,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
tivantinib,MDAMB231,1.55,active,C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65
fenoterol,MDAMB231,1.53,active,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O
FPL-62064,MDAMB231,1.5,active,COC1=CC=C(C=C1)NC2=NN(C=C2)C3=CC=CC=C3
sulbutiamine,MDAMB231,1,inactive,CC1=NC=C(C(=N1)N)CN(/C(=C(\SS/C(=C(\N(C=O)CC2=CN=C(N=C2N)C)/C)/CCOC(=O)C(C)C)/CCOC(=O)C(C)C)/C)C=O
doxofylline,MDAMB231,1,inactive,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3
dapsone,MDAMB231,1,inactive,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
ivacaftor,MDAMB231,1,inactive,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
AZD-7687,MDAMB231,1,inactive,CC1=C(N=C(C(=N1)C)C(=O)N)C2=CC=C(C=C2)C3CCC(CC3)CC(=O)O
BIX-02189,MDAMB231,1,inactive,CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O
exalamide,MDAMB231,1,inactive,CCCCCCOC1=CC=CC=C1C(=O)N
siguazodan,MDAMB231,1,inactive,CC1CC(=O)NN=C1C2=CC=C(C=C2)NC(=NC)NC#N
pinacidil,MDAMB231,0.99,inactive,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1
piketoprofen,MDAMB231,0.99,inactive,CC1=CC(=NC=C1)NC(=O)C(C)C2=CC(=CC=C2)C(=O)C3=CC=CC=C3
oxiperomide,MDAMB231,0.99,inactive,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCOC4=CC=CC=C4
efavirenz,MDAMB231,0.99,inactive,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
lobenzarit,MDAMB231,0.99,inactive,C1=CC=C(C(=C1)C(=O)O)NC2=C(C=CC(=C2)Cl)C(=O)O
spironolactone,MDAMB231,0.99,inactive,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
rasagiline,MDAMB231,0.99,inactive,C#CCN[C@@H]1CCC2=CC=CC=C12
VTP-27999,MDAMB231,0.99,inactive,CN[C@@H](C[C@H]1CCCOC1)CNC(=O)N2CCC[C@H](C2)[C@H](C3=CC(=CC=C3)Cl)OCCNC(=O)OC
lasalocid,MDAMB231,0.98,inactive,CC[C@H]([C@@H]1[C@H](C[C@@](O1)(CC)[C@H]2CC[C@@]([C@@H](O2)C)(CC)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O
MF-101,MDAMB231,0.98,inactive,C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O
PH-797804,MDAMB231,0.98,inactive,CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C
lorcaserin,MDAMB231,0.98,inactive,C[C@H]1CNCCC2=C1C=C(C=C2)Cl
taltirelin,MDAMB231,0.98,inactive,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N
camptothecin,MDAMB231,0.98,inactive,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O
armodafinil,MDAMB231,0.97,inactive,C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N
MK-2461,MDAMB231,0.97,inactive,CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)NS(=O)(=O)N(C)C[C@@H]5COCCO5)N=C2
amodiaquine,MDAMB231,0.97,inactive,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O
ATN-161,MDAMB231,0.97,inactive,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N
BVD-523,MDAMB231,0.97,inactive,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl
sofalcone,MDAMB231,0.97,inactive,CC(=CCOC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C
ticlopidine,MDAMB231,0.97,inactive,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
nicergoline,MDAMB231,0.96,inactive,CN1C[C@@H](C[C@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br
cefoperazone,MDAMB231,0.96,inactive,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O
acipimox,MDAMB231,0.96,inactive,CC1=CN=C(C=[N+]1[O-])C(=O)O
pinitol,MDAMB231,0.96,inactive,COC1[C@@H]([C@H](C([C@@H]([C@@H]1O)O)O)O)O
alagebrium,MDAMB231,0.96,inactive,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C
dideoxyadenosine,MDAMB231,0.96,inactive,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C(N=CN=C32)N
tanaproget,MDAMB231,0.96,inactive,CC1(C2=C(C=CC(=C2)C3=CC=C(N3C)C#N)NC(=S)O1)C
desoxypeganine,MDAMB231,0.95,inactive,C1CC2=NC3=CC=CC=C3CN2C1
JTE-907,MDAMB231,0.95,inactive,CCCCCOC1=C(C=CC2=C1NC(=O)C(=C2)C(=O)NCC3=CC4=C(C=C3)OCO4)OC
ivermectin,MDAMB231,0.95,inactive,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C
prednisone,MDAMB231,0.95,inactive,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C
SB-203580,MDAMB231,0.95,inactive,CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F
vidarabine,MDAMB231,0.94,inactive,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N
CGS-20625,MDAMB231,0.94,inactive,COC1=CC=C(C=C1)N2C(=O)C3=CN=C4CCCCCC4=C3N2
voriconazole,MDAMB231,0.94,inactive,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
nafamostat,MDAMB231,0.94,inactive,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
esmolol,MDAMB231,0.93,inactive,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O
curcumin,MDAMB231,0.93,inactive,COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O
varenicline,MDAMB231,0.92,inactive,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
glibenclamide,MDAMB231,0.92,inactive,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
nilotinib,MDAMB231,0.92,inactive,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
estramustine,MDAMB231,0.92,inactive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl
escitalopram,MDAMB231,0.92,inactive,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
GDC-0199,MDAMB231,0.91,inactive,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
erteberel,MDAMB231,0.91,inactive,C1C[C@H]2[C@@H](C1)C3=C(C=CC(=C3)O)O[C@H]2C4=CC=C(C=C4)O
naftifine,MDAMB231,0.91,inactive,CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32
anamorelin,MDAMB231,0.91,inactive,CC(C)(C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@](C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N
sasapyrine,MDAMB231,0.91,inactive,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O
KX-2391,MDAMB231,0.91,inactive,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4
mirtazapine,MDAMB231,0.9,inactive,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
RG-7388,MDAMB231,0.9,inactive,CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F
nefazodone,MDAMB231,0.9,inactive,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
febuxostat,MDAMB231,0.9,inactive,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O
glycopyrrolate,MDAMB231,0.89,inactive,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]
donepezil,MDAMB231,0.89,inactive,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
balsalazide,MDAMB231,0.89,inactive,C1=CC(=CC=C1C(=O)NCCC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O
temozolomide,MDAMB231,0.89,inactive,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CB-10-277,MDAMB231,0.89,inactive,CN(C)N=NC1=CC=C(C=C1)C(=O)O
fexofenadine,MDAMB231,0.89,inactive,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
BIIB-021,MDAMB231,0.89,inactive,CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N
nizofenone,MDAMB231,0.89,inactive,CCN(CC)CC1=NC=CN1C2=C(C=C(C=C2)[N+](=O)[O-])C(=O)C3=CC=CC=C3Cl
pranlukast,MDAMB231,0.89,inactive,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5
PF-04447943,MDAMB231,0.89,inactive,C[C@@H]1CN(C[C@H]1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=NC=CC=N5
sulfafurazole,MDAMB231,0.88,inactive,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N
MBX-2982,MDAMB231,0.88,inactive,CCC1=CN=C(N=C1)N2CCC(CC2)C3=NC(=CS3)COC4=CC=C(C=C4)N5C=NN=N5
bitopertin,MDAMB231,0.88,inactive,C[C@@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F
nikethamide,MDAMB231,0.88,inactive,CCN(CC)C(=O)C1=CN=CC=C1
VX-745,MDAMB231,0.88,inactive,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl
naftopidil,MDAMB231,0.87,inactive,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O
trazodone,MDAMB231,0.87,inactive,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
eperezolid,MDAMB231,0.87,inactive,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F
isoniazid,MDAMB231,0.87,inactive,C1=CN=CC=C1C(=O)NN
MK-3207,MDAMB231,0.87,inactive,C1CCC2(C1)C(=O)N([C@@H](CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(C[C@@]6(C5)C7=C(NC6=O)N=CC=C7)C=C4
acetazolamide,MDAMB231,0.87,inactive,CC(=O)NC1=NN=C(S1)S(=O)(=O)N
SB-216763,MDAMB231,0.87,inactive,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl
ZSTK-474,MDAMB231,0.87,inactive,C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5
alprostadil,MDAMB231,0.87,inactive,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O
adarotene,MDAMB231,0.87,inactive,C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC=C(C=C5)/C=C/C(=O)O)O
pazufloxacin,MDAMB231,0.86,inactive,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O
BMS-927711,MDAMB231,0.86,inactive,C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6
metolazone,MDAMB231,0.86,inactive,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
VX-661,MDAMB231,0.86,inactive,CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F
vismodegib,MDAMB231,0.86,inactive,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl
AGI-6780,MDAMB231,0.86,inactive,C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F
CPI-613,MDAMB231,0.86,inactive,C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2
tadalafil,MDAMB231,0.86,inactive,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
nimodipine,MDAMB231,0.85,inactive,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
sumatriptan,MDAMB231,0.85,inactive,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
amitifadine,MDAMB231,0.85,inactive,C1[C@H]2[C@@]1(CNC2)C3=CC(=C(C=C3)Cl)Cl
aprepitant,MDAMB231,0.85,inactive,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
ZM-447439,MDAMB231,0.84,inactive,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5
fenticonazole,MDAMB231,0.84,inactive,C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl
zaleplon,MDAMB231,0.84,inactive,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
molindone,MDAMB231,0.84,inactive,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C
ampalex,MDAMB231,0.84,inactive,C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2
foretinib,MDAMB231,0.84,inactive,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
irbesartan,MDAMB231,0.83,inactive,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
ketoprofen,MDAMB231,0.83,inactive,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
SNX-2112,MDAMB231,0.83,inactive,CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C
fingolimod,MDAMB231,0.83,inactive,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N
L-690330,MDAMB231,0.83,inactive,CC(OC1=CC=C(C=C1)O)(P(=O)(O)O)P(=O)(O)O
inositol,MDAMB231,0.83,inactive,C1(C(C(C(C(C1O)O)O)O)O)O
vemurafenib,MDAMB231,0.83,inactive,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F
otilonium,MDAMB231,0.82,inactive,CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC
SGX-523,MDAMB231,0.82,inactive,CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2
rupatadine,MDAMB231,0.82,inactive,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2
repaglinide,MDAMB231,0.82,inactive,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
telatinib,MDAMB231,0.82,inactive,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl
eflornithine,MDAMB231,0.82,inactive,C(CC(C(F)F)(C(=O)O)N)CN
benzylpenicillin,MDAMB231,0.82,inactive,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
CX-5461,MDAMB231,0.82,inactive,CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C
indapamide,MDAMB231,0.82,inactive,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
candesartan,MDAMB231,0.81,inactive,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
betulinic-acid,MDAMB231,0.81,inactive,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)O
NVP-BGJ398,MDAMB231,0.81,inactive,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl
TGX-221,MDAMB231,0.81,inactive,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4
A-66,MDAMB231,0.81,inactive,CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CSC(=N3)C(C)(C)C
reserpine,MDAMB231,0.81,inactive,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
urapidil,MDAMB231,0.8,inactive,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC
clinafloxacin,MDAMB231,0.8,inactive,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O
valproic-acid,MDAMB231,0.8,inactive,CCCC(CCC)C(=O)O
enprofylline,MDAMB231,0.8,inactive,CCCN1C2=C(C(=O)NC1=O)NC=N2
levamisole,MDAMB231,0.79,inactive,C1CSC2=N[C@H](CN21)C3=CC=CC=C3
nefiracetam,MDAMB231,0.79,inactive,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
novobiocin,MDAMB231,0.79,inactive,CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O
D-serine,MDAMB231,0.79,inactive,C([C@H](C(=O)O)N)O
duloxetine,MDAMB231,0.79,inactive,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
sildenafil,MDAMB231,0.79,inactive,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
ethylenediaminetetraacetic-acid,MDAMB231,0.79,inactive,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O
gemifloxacin,MDAMB231,0.78,inactive,CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
flumatinib,MDAMB231,0.78,inactive,CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5
VX-809,MDAMB231,0.78,inactive,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O
quetiapine,MDAMB231,0.78,inactive,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
amantadine,MDAMB231,0.78,inactive,C1C2CC3CC1CC(C2)(C3)N
digoxin,MDAMB231,0.78,inactive,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
timonacic,MDAMB231,0.77,inactive,C1C(NCS1)C(=O)O
letrozole,MDAMB231,0.77,inactive,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
sulbactam,MDAMB231,0.77,inactive,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C
IOWH-032,MDAMB231,0.77,inactive,C1=CC=C(C=C1)OC2=CC=C(C=C2)CNC(=O)C3=NC(=NO3)C4=CC(=C(C(=C4)Br)O)Br
CL-218872,MDAMB231,0.77,inactive,CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)C(F)(F)F
avagacestat,MDAMB231,0.77,inactive,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl
NVP-BEZ235,MDAMB231,0.77,inactive,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5
DPI-201106,MDAMB231,0.77,inactive,C1CN(CCN1CC(COC2=CC=CC3=C2C=C(N3)C#N)O)C(C4=CC=CC=C4)C5=CC=CC=C5
cevimeline,MDAMB231,0.76,inactive,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1
lurasidone,MDAMB231,0.76,inactive,C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O
tiagabine,MDAMB231,0.76,inactive,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C
lonidamine,MDAMB231,0.76,inactive,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O
tecastemizole,MDAMB231,0.76,inactive,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
PA-824,MDAMB231,0.76,inactive,C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F
temoporfin,MDAMB231,0.76,inactive,C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O
pilocarpine,MDAMB231,0.75,inactive,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
cholic-acid,MDAMB231,0.75,inactive,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C
valdecoxib,MDAMB231,0.75,inactive,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
safinamide,MDAMB231,0.75,inactive,C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F
ALW-II-49-7,MDAMB231,0.75,inactive,CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=CN=CC(=C3)C(=O)N
ACY-1215,MDAMB231,0.75,inactive,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO
emedastine,MDAMB231,0.75,inactive,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
hydroflumethiazide,MDAMB231,0.75,inactive,C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1
glipizide,MDAMB231,0.75,inactive,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
lesinurad,MDAMB231,0.75,inactive,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O
exherin,MDAMB231,0.74,inactive,C[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CN=CN2)NC(=O)C)C(=O)N)C(C)C
clomifene,MDAMB231,0.74,inactive,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\Cl)/C3=CC=CC=C3
raloxifene,MDAMB231,0.74,inactive,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
dipraglurant,MDAMB231,0.74,inactive,C1=CC=NC(=C1)C#CCCC2=CN3C=C(C=CC3=N2)F
JNJ-26481585,MDAMB231,0.74,inactive,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO
phenylbutyrate,MDAMB231,0.74,inactive,C1=CC=C(C=C1)CCCC(=O)O
AGP-103,MDAMB231,0.74,inactive,CCCCCCCCCCCCCCCCCCCCCC(=O)O
emtricitabine,MDAMB231,0.74,inactive,C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F
tagatose,MDAMB231,0.74,inactive,C1[C@H]([C@@H]([C@@H](C(O1)(CO)O)O)O)O
CO-102862,MDAMB231,0.74,inactive,C1=CC(=CC=C1/C=N/NC(=O)N)OC2=CC=C(C=C2)F
AV-608,MDAMB231,0.74,inactive,C1CN([C@@H](C[C@H]1NC(=O)C2=CC=NC3=CC=CC=C23)CC4=CC=C(C=C4)Cl)C(=O)C5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F
ozagrel,MDAMB231,0.74,inactive,C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
maraviroc,MDAMB231,0.73,inactive,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C
brequinar,MDAMB231,0.73,inactive,CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O
diethylcarbamazine,MDAMB231,0.73,inactive,CCN(CC)C(=O)N1CCN(CC1)C
nutlin-3,MDAMB231,0.73,inactive,CC(C)OC1=C(C=CC(=C1)OC)C2=NC(C(N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl
safingol,MDAMB231,0.73,inactive,CCCCCCCCCCCCCCC[C@@H]([C@H](CO)N)O
oxybuprocaine,MDAMB231,0.72,inactive,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N
phenazone,MDAMB231,0.72,inactive,CC1=CC(=O)N(N1C)C2=CC=CC=C2
acrivastine,MDAMB231,0.72,inactive,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O
masitinib,MDAMB231,0.72,inactive,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5
salirasib,MDAMB231,0.72,inactive,CC(=CCC/C(=C/CC/C(=C/CSC1=CC=CC=C1C(=O)O)/C)/C)C
nicotinamide,MDAMB231,0.72,inactive,C1=CC(=CN=C1)C(=O)N
GDC-0068,MDAMB231,0.71,inactive,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O
macitentan,MDAMB231,0.71,inactive,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br
darunavir,MDAMB231,0.71,inactive,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
faropenem,MDAMB231,0.71,inactive,C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)[C@H]3CCCO3)C(=O)O)O
etomidate,MDAMB231,0.71,inactive,CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2
asymmetrical-dimethylarginine,MDAMB231,0.71,inactive,CN(C)C(=NCCC[C@@H](C(=O)O)N)N
buparlisib,MDAMB231,0.71,inactive,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
probenecid,MDAMB231,0.71,inactive,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
guanethidine,MDAMB231,0.7,inactive,C1CCCN(CCC1)CCN=C(N)N
prazosin,MDAMB231,0.7,inactive,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
LY-2811376,MDAMB231,0.7,inactive,C[C@]1(CCSC(=N1)N)C2=C(C=C(C(=C2)C3=CN=CN=C3)F)F
nimesulide,MDAMB231,0.7,inactive,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
cordycepin,MDAMB231,0.7,inactive,C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO
rottlerin,MDAMB231,0.7,inactive,CC1=C(C(=C(C(=C1O)C(=O)C)O)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)/C=C/C4=CC=CC=C4)O)O
alvimopan,MDAMB231,0.7,inactive,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O
BMY-14802,MDAMB231,0.7,inactive,C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
NSC-4644,MDAMB231,0.69,inactive,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO
biperiden,MDAMB231,0.69,inactive,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O
fidarestat,MDAMB231,0.69,inactive,C1[C@H](OC2=C([C@]13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N
felodipine,MDAMB231,0.69,inactive,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
mestranol,MDAMB231,0.69,inactive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC
zafirlukast,MDAMB231,0.69,inactive,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
AM-24,MDAMB231,0.69,inactive,C1=C(C=C(C(=C1I)O)I)I
almitrine,MDAMB231,0.69,inactive,C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C
clofibrate,MDAMB231,0.69,inactive,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl
orphenadrine,MDAMB231,0.68,inactive,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
RU-58841,MDAMB231,0.68,inactive,CC1(C(=O)N(C(=O)N1CCCCO)C2=CC(=C(C=C2)C#N)C(F)(F)F)C
dantrolene,MDAMB231,0.68,inactive,C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]
GW-842166,MDAMB231,0.68,inactive,C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl
atorvastatin,MDAMB231,0.68,inactive,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
anagrelide,MDAMB231,0.68,inactive,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3
cianidanol,MDAMB231,0.67,inactive,C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O
temazepam,MDAMB231,0.67,inactive,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
tetrindole,MDAMB231,0.67,inactive,C1CCC(CC1)C2=CC3=C(C=C2)N4CCNC5C4=C3CCC5.Cl
vilazodone,MDAMB231,0.67,inactive,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N
perindopril,MDAMB231,0.66,inactive,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O
lorglumide,MDAMB231,0.66,inactive,CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl
pimozide,MDAMB231,0.66,inactive,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
PSI-6130,MDAMB231,0.66,inactive,C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O)F
tamsulosin,MDAMB231,0.65,inactive,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
tedizolid,MDAMB231,0.65,inactive,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F
cabergoline,MDAMB231,0.65,inactive,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
fluspirilene,MDAMB231,0.65,inactive,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
ecabet,MDAMB231,0.65,inactive,CC(C)C1=C(C=C2C(=C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C(=O)O)C)S(=O)(=O)O
ALX-5407,MDAMB231,0.65,inactive,CN(CC[C@H](C1=CC=C(C=C1)F)OC2=CC=C(C=C2)C3=CC=CC=C3)CC(=O)O
amrinone,MDAMB231,0.65,inactive,C1=CN=CC=C1C2=CNC(=O)C(=C2)N
TG-100115,MDAMB231,0.65,inactive,C1=CC(=CC(=C1)O)C2=NC3=C(N=C(N=C3N=C2C4=CC(=CC=C4)O)N)N
cinepazide,MDAMB231,0.64,inactive,COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3
tamoxifen,MDAMB231,0.64,inactive,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3
zidovudine,MDAMB231,0.64,inactive,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
PK-11195,MDAMB231,0.63,inactive,CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl
etofenamate,MDAMB231,0.63,inactive,C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F
pralatrexate,MDAMB231,0.63,inactive,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
NXY-059,MDAMB231,0.63,inactive,CC(C)(C)/[N+](=C/C1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])/[O-].[Na+].[Na+]
SR-2640,MDAMB231,0.63,inactive,C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=CC(=C3)NC4=CC=CC=C4C(=O)O
MD-920,MDAMB231,0.63,inactive,C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)O)OC2=O)O
bezafibrate,MDAMB231,0.63,inactive,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
dienogest,MDAMB231,0.63,inactive,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O
dexfenfluramine,MDAMB231,0.63,inactive,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
avasimibe,MDAMB231,0.62,inactive,CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
tolbutamide,MDAMB231,0.62,inactive,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
ABT-737,MDAMB231,0.62,inactive,CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]
cinnarizine,MDAMB231,0.62,inactive,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
acifran,MDAMB231,0.62,inactive,CC1(C(=O)C=C(O1)C(=O)O)C2=CC=CC=C2
sarcosine,MDAMB231,0.62,inactive,CNCC(=O)O
oseltamivir-carboxylate,MDAMB231,0.62,inactive,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)O
resatorvid,MDAMB231,0.62,inactive,CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl
AICA-ribonucleotide,MDAMB231,0.61,inactive,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N
CI-966,MDAMB231,0.61,inactive,C1CN(CC(=C1)C(=O)O)CCOC(C2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)C(F)(F)F
donitriptan,MDAMB231,0.61,inactive,C1CN(CCN1C2=CC=C(C=C2)C#N)C(=O)COC3=CC4=C(C=C3)NC=C4CCN
pazopanib,MDAMB231,0.61,inactive,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
oxybutynin,MDAMB231,0.6,inactive,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
methyldopa,MDAMB231,0.6,inactive,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N
probucol,MDAMB231,0.6,inactive,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C
zolpidem,MDAMB231,0.6,inactive,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
bemegride,MDAMB231,0.6,inactive,CCC1(CC(=O)NC(=O)C1)C
meclizine,MDAMB231,0.6,inactive,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl
famciclovir,MDAMB231,0.6,inactive,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C
pramipexole,MDAMB231,0.6,inactive,CCCN[C@H]1CCC2=C(C1)SC(=N2)N
LY-2090314,MDAMB231,0.6,inactive,C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7
lafutidine,MDAMB231,0.6,inactive,C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3
cilostazol,MDAMB231,0.6,inactive,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
L-655240,MDAMB231,0.6,inactive,CC1=C(N(C2=C1C=C(C=C2)F)CC3=CC=C(C=C3)Cl)CC(C)(C)C(=O)O
SB-705498,MDAMB231,0.6,inactive,C1CN(C[C@@H]1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F
tebipenem,MDAMB231,0.59,inactive,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O
moxifloxacin,MDAMB231,0.59,inactive,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
itopride,MDAMB231,0.59,inactive,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC
BMS-299897,MDAMB231,0.59,inactive,C[C@H](C1=C(C=C(C=C1)F)CCCC(=O)O)N(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl
losartan,MDAMB231,0.58,inactive,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
rimonabant,MDAMB231,0.58,inactive,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl
chlorambucil,MDAMB231,0.58,inactive,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
goserelin-acetate,MDAMB231,0.58,inactive,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6
histamine,MDAMB231,0.58,inactive,C1=C(NC=N1)CCN
rilpivirine,MDAMB231,0.58,inactive,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N
ginkgolide-b,MDAMB231,0.58,inactive,C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O
KU-55933,MDAMB231,0.57,inactive,C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4
GNF-2,MDAMB231,0.57,inactive,C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F
ambrisentan,MDAMB231,0.57,inactive,CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
GSK-1904529A,MDAMB231,0.57,inactive,CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F
tomelukast,MDAMB231,0.57,inactive,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCC2=NNN=N2
fomocaine,MDAMB231,0.57,inactive,C1COCCN1CCCC2=CC=C(C=C2)COC3=CC=CC=C3
lacosamide,MDAMB231,0.56,inactive,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1
estramustine-phosphate,MDAMB231,0.56,inactive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OP(=O)(O)O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl
clozapine,MDAMB231,0.56,inactive,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
dexniguldipine,MDAMB231,0.55,inactive,CC1=C([C@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC
enoxolone,MDAMB231,0.55,inactive,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)O
GSK-2636771,MDAMB231,0.55,inactive,CC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C(C=C(C=C32)N4CCOCC4)C(=O)O)C
griseofulvin,MDAMB231,0.55,inactive,C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
metergoline,MDAMB231,0.54,inactive,CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5
melperone,MDAMB231,0.54,inactive,CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F
cytarabine,MDAMB231,0.54,inactive,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
lerisetron,MDAMB231,0.54,inactive,C1CN(CCN1)C2=NC3=CC=CC=C3N2CC4=CC=CC=C4
API-001,MDAMB231,0.54,inactive,CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
tipiracil,MDAMB231,0.54,inactive,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl
valsartan,MDAMB231,0.53,inactive,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
ranitidine,MDAMB231,0.53,inactive,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C
maxacalcitol,MDAMB231,0.53,inactive,C[C@@H]([C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)OCCC(C)(C)O
mestinon,MDAMB231,0.52,inactive,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]
torin-2,MDAMB231,0.52,inactive,C1=CC(=CC(=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CN=C(C=C5)N)C(F)(F)F
phenprocoumon,MDAMB231,0.52,inactive,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
rilmenidine,MDAMB231,0.51,inactive,C1CC1C(C2CC2)NC3=NCCO3
bopindolol,MDAMB231,0.51,inactive,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C3=CC=CC=C3
darifenacin,MDAMB231,0.5,inactive,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
hesperidin,MDAMB231,0.5,inactive,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
urea,MDAMB231,0.5,inactive,C(=O)(N)N
econazole,MDAMB231,0.5,inactive,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
dolasetron,MDAMB231,0.5,inactive,C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54
timofibrate,MDAMB231,0.49,inactive,CC(C)(C(=O)N1CSCC1C(=O)O)OC2=CC=C(C=C2)Cl
iguratimod,MDAMB231,0.49,inactive,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3
melatonin,MDAMB231,0.49,inactive,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
benazepril,MDAMB231,0.48,inactive,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O
MK-2206,MDAMB231,0.48,inactive,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N
radezolid,MDAMB231,0.48,inactive,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F
miconazole,MDAMB231,0.48,inactive,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
AS-601245,MDAMB231,0.47,inactive,C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4
rifaximin,MDAMB231,0.47,inactive,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C
tacalcitol,MDAMB231,0.47,inactive,C[C@H](CC[C@H](C(C)C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
ercalcitriol,MDAMB231,0.47,inactive,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
KD-023,MDAMB231,0.46,inactive,CCCCCCCCCCCCCCOC1=CC=C(O1)C(=O)O
methiopril,MDAMB231,0.46,inactive,C[C@@H]1CCC[C@@H](N1C(=O)CCSC(=O)C)C(=O)O
miglitol,MDAMB231,0.46,inactive,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O
DMP-777,MDAMB231,0.45,inactive,CCC[C@H](C1=CC2=C(C=C1)OCO2)NC(=O)N3[C@H](C(C3=O)(CC)CC)OC4=CC=C(C=C4)C(=O)N5CCN(CC5)C
bavisant,MDAMB231,0.45,inactive,C1CC1N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4
dabigatran-etexilate,MDAMB231,0.45,inactive,CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4
orteronel,MDAMB231,0.44,inactive,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)[C@]3(CCN4C3=CN=C4)O
epirizole,MDAMB231,0.44,inactive,CC1=CC(=NC(=N1)N2C(=CC(=N2)C)OC)OC
tirofiban,MDAMB231,0.44,inactive,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
guanadrel,MDAMB231,0.42,inactive,C1CCC2(CC1)OCC(O2)CN=C(N)N
azelastine,MDAMB231,0.42,inactive,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl
theobromine,MDAMB231,0.42,inactive,CN1C=NC2=C1C(=O)NC(=O)N2C
tioconazole,MDAMB231,0.42,inactive,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl
BX-912,MDAMB231,0.41,inactive,C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br
anecortave-acetate,MDAMB231,0.4,inactive,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)CC[C@@]43C)C)O
lamotrigine,MDAMB231,0.39,inactive,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
SU-11274,MDAMB231,0.34,inactive,CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)/C=C\3/C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O
rigosertib,MDAMB231,0.29,inactive,COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)O
